The efficacy of carnitine complex(The efficacy of carnitine complex(GODEX ? R ) for the patients with moderate alcoholic liver disease: a multicenter, randomized, double blind, phase ? study

Kangdong Sacred Heart Hospital0 个研究点目标入组 38 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•1.Over 19 years of age
•2.Individual who consume alcohol more than 40g per day for men and 20g for women
•3.Individual who has ADUIT K score over than 20 for men and 10 for women
•4.Individual who has their ALT and AST level above than normal range.
•5.40 IU/L =ALT, AST= 400 IU/L and AST/ALT= 1
•6.Individual who has their GGT level above than normal range.
•7.- GGT ; Men > 71 IU/L, Women > 42 IU/

•1.Individual who has allergic response to Investigational product
•2.Parkinson’s disease patients who are taking Levodopa for treatment
•3.Individual who has Maddrey discriminant function score above 32
•4.Individual with Portal hypertension complications
•5.Individual with hepatorenal syndrome
•6.Individual with viral liver diseases, hepatocellular Carcinoma, liver disease from drug-taking or other liver disease which can affect the results of trial.
•7.Individual who experienced bacterial hepatitis in recent 6 months
•8.Individual with pancreatitis and HIV
•9.Individual with cardiac insufficiency, ischemic cardiomyopathy, respiratory failure
•10.Individuals who are taking Psychotropic medication except antidepressant
•11.Pregnant women, lactating women
•12.Individuals who are considered unsuitable by investigators due to other reasons
•13.Individual who didn’t consent with Investigator Consent Form
•14.Individuals who are unable to follow the introductions regarding the progress of trial for their medical, psychological, social, geographical conditions

发起方